Cognitive dysfunction: cause or consequence of bipolar disorder?

2005 ◽  
pp. 163-174
Author(s):  
Zihang Pan ◽  
Roger S. McIntyre

Cognitive dysfunction is a symptom domain across multiple psychiatric disorders. Cognitive deficits in individuals with major depressive disorder (MDD) and bipolar disorder (BD) are significant contributors to global occupational and functional disability. The subdomains of learning and memory, executive function, processing speed, and attention and concentration are significantly impaired in individuals with MDD and BD. Treatment outcomes of cognitive symptoms with first-line agents have been suboptimal. Neuroinflammatory pathways are hypothesized to play key roles in the pathoaetiology of cognitive symptoms in MDD and BD. There is compelling evidence to suggest that elevation of systemic proinflammatory cytokines is involved in neurotoxicity, apoptosis, and aberrant neurocircuit function. These substrates offer opportunities to identify relevant biomarkers, refine treatment targets, and manage cognitive deficits across major psychiatric illnesses. This chapter provides an overview of cognitive symptoms across MDD and BD and discusses potential neurobiological substrates contributing to cognitive dysfunction.


2009 ◽  
Vol 17 (12) ◽  
pp. 1004-1011 ◽  
Author(s):  
Shang-Ying Tsai ◽  
Chian-Jue Kuo ◽  
Kuo-Hsuan Chung ◽  
Yi-Lin Huang ◽  
Hsin-Chien Lee ◽  
...  

2012 ◽  
Vol 53 (7) ◽  
pp. 775-781 ◽  
Author(s):  
Lindsay S. Schenkel ◽  
Amy E. West ◽  
Rachel Jacobs ◽  
John A. Sweeney ◽  
Mani N. Pavuluri

2017 ◽  
Vol 27 ◽  
pp. S821
Author(s):  
R.H. McAllister-Williams ◽  
A.J. Bradley ◽  
P. Gallagher ◽  
K.N. Anderson

2017 ◽  
Vol 41 (S1) ◽  
pp. S15-S16
Author(s):  
K. Miskowiak

Cognitive dysfunction, including memory and concentration difficulty, is an emerging treatment target in bipolar disorder. However, a key challenge in the management of these cognitive deficits is the lack of treatments with robust effects on cognition. Further, it is unclear how cognitive dysfunction should be assessed and addressed in the clinical treatment of the disorder. This talk will review the evidence for cognitive impairment in bipolar disorder, including its severity, persistence and impact on patients’ functional recovery. It will then discuss when and how to assess cognition and present some new feasible screening tools for cognitive dysfunction. Finally, it will highlight some novel candidate cognition treatments.Disclosure of interestI have acted as a consultant and received honoraria from Lundbeck and Allergan.


2018 ◽  
Vol 45 (5) ◽  
pp. 135-135
Author(s):  
Cássio Silveira de Jesús ◽  
Marlos Vasconcelos Rocha ◽  
Ângela Miranda-Scippa

Sign in / Sign up

Export Citation Format

Share Document